Rigel Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 04/08/2026 | Mar 2026Filed 04/08/2026 | Sep 2025Filed 04/11/2025 | Jun 2025Filed 04/08/2026 | Mar 2025Filed 04/08/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 05/08/2025 | Mar 2024Filed 06/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $79 | $59 | $69 | $102 | $53 | $55 | $37 | $30 | |
| $17 | $8.7 | $28 | $60 | $11 | $12 | −$1 | −$8.2 | |
| $0.88 | $0.44 | $1.46 | $3.28 | $0.63 | $0.70 | −$0.06 | −$0.47 | |
| 20 | 20 | 19 | 18 | 18 | 18 | 18 | 18 |
Trend